Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array

Abstract

Extracellular vesicles (EVs) are small particles with phospholipid bilayers that carry a diverse range of cargoes including nucleic acids, proteins and metabolites. EVs have important roles in various cellular processes and are increasingly recognized for their ubiquitous role in cell–cell communications and potential applications in therapeutics and diagnostics. Although many methods have been developed for the characterization and measurement of EVs, analyzing them from biofluids remains a challenge with regard to throughput and sensitivity. Recently, we introduced an approach to facilitate high-throughput analysis of EVs from trace amounts of sample. In this method, an amphiphile–dendrimer supramolecular probe (ADSP) is coated onto a nitrocellulose membrane for array-based capture and to enable an in situ immunoblotting assay. Here, we describe the protocol for our array-based method of EV profiling. We describe an enhanced version of the method that incorporates an automated printing workstation, ensuring high throughput and reproducibility. We further demonstrate the use of our array to profile specific glycosylations on the EV surface using click chemistry of an azide group introduced by metabolic labeling. In this protocol, the synthesis of ADSP and the fabrication of ADSP nitrocellulose membrane array can be completed on the same day. EVs are efficiently captured from biological or clinical samples through a 30-min incubation, followed by an immunoblotting assay within a 3-h window, thus providing a high-throughput platform for EV isolation and in situ targeted analysis of EV proteins and their modifications.

Key points

  • This protocol uses an amphiphile–dendrimer supramolecular probe to capture extracellular vesicles from biofluids and cell culture medium to avoid time-consuming sample processing and the cocapture of nucleic acids and proteins associated with ultracentrifugation-based purification approaches.

  • The use of a chemical affinity probe coating onto nitrocellulose membrane enables high-throughput, array-based enrichment and in situ immunoblotting of extracellular vesicle proteins for relative concentration assay.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Scheme showing the interaction between ADSP and the phospholipid layer of EVs.
Fig. 2: Workflow for array-based high-throughput capture and analysis of EVs.
Fig. 3: Detection limit and linear range of ADSP array for plasma EVs.
Fig. 4: Detection limit and linear range of ADSP array for urine EVs.
Fig. 5: Analysis of clinical plasma samples by ADSP array.
Fig. 6: Analysis of clinical urine samples by ADSP array.
Fig. 7: Analysis of Ac4ManNAz-labeled EVs from cells by ADSP array.

Similar content being viewed by others

Data availability

The authors declare that the main data discussed in this protocol are available in the supporting primary research papers. Further parameters or details of the experiments are available from the corresponding author upon reasonable request.

References

  1. Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science https://doi.org/10.1126/science.aau6977 (2020).

  2. Cocucci, E. & Meldolesi, J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 25, 364–372 (2015).

    Article  CAS  PubMed  Google Scholar 

  3. Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Marar, C., Starich, B. & Wirtz, D. Extracellular vesicles in immunomodulation and tumor progression. Nat. Immunol. 22, 560–570 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Buzas, E. I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 23, 236–250 (2023).

    Article  CAS  PubMed  Google Scholar 

  6. Lou, P. et al. Neonatal-tissue-derived extracellular vesicle therapy (NEXT): a potent strategy for precision regenerative medicine. Adv. Mater. 35, e2300602 (2023).

    Article  PubMed  Google Scholar 

  7. Dixson, A. C., Dawson, T. R., Di Vizio, D. & Weaver, A. M. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat. Rev. Mol. Cell Biol. 24, 454–476 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).

    Article  PubMed  Google Scholar 

  9. Tkach, M. & Théry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226–1232 (2016).

    Article  CAS  PubMed  Google Scholar 

  10. Kourembanas, S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu. Rev. Physiol. 77, 13–27 (2015).

    Article  CAS  PubMed  Google Scholar 

  11. Kalluri, R. & McAndrews, K. M. The role of extracellular vesicles in cancer. Cell 186, 1610–1626 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Becker, A. et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30, 836–848 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yu, D. et al. Exosomes as a new frontier of cancer liquid biopsy. Mol. Cancer https://doi.org/10.1186/s12943-022-01509-9 (2022).

  15. Boukouris, S. & Mathivanan, S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteom. Clin. Appl. 9, 358–367 (2015).

    Article  CAS  Google Scholar 

  16. Martins, T. S., Catita, J., Rosa, I. M., Silva, O. & Henriques, A. G. Exosome isolation from distinct biofluids using precipitation and column-based approaches. PLoS ONE https://doi.org/10.1371/journal.pone.0198820 (2018).

  17. Chen, J. C. et al. Review on strategies and technologies for exosome isolation and purification. Front. Bioeng. Biotechnol. https://doi.org/10.3389/fbioe.2021.811971 (2022).

  18. Guan, S. et al. Characterization of urinary exosomes purified with size exclusion chromatography and ultracentrifugation. J. Proteome Res. 19, 2217–2225 (2020).

    Article  CAS  PubMed  Google Scholar 

  19. Pathan, M. et al. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 47, D516–D519 (2019).

    Article  CAS  PubMed  Google Scholar 

  20. Omrani, M. et al. Global trend in exosome isolation and application: an update concept in management of diseases. Mol. Cell Biochem. https://doi.org/10.1007/s11010-023-04756-6 (2023).

  21. Sódar, B. W. et al. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci. Rep. 6, 24316 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gardiner, C. et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J. Extracell. Vesicles 5, 32945 (2016).

    Article  PubMed  Google Scholar 

  23. Jeppesen, D. K. et al. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J. Extracell. Vesicles 3, 25011 (2014).

    Article  PubMed  Google Scholar 

  24. Welton, J. L. et al. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. J. Extracell. Vesicles 5, 31209 (2016).

    Article  PubMed  Google Scholar 

  25. Wu, X. F., Li, L., Iliuk, A. & Tao, W. A. Highly efficient phosphoproteome capture and analysis from urinary extracellular vesicles. J. Proteome Res. 17, 3308–3316 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sun, J. et al. Profiling phosphoproteome landscape in circulating extracellular vesicles from microliters of biofluids through functionally tunable paramagnetic separation. Angew. Chem. Int. Ed. https://doi.org/10.1002/anie.202305668 (2023).

  27. Feng, X. et al. Supramolecular exosome array for efficient capture and in situ detection of protein biomarkers. Anal. Chem. 95, 2812–2821 (2023).

    Article  CAS  PubMed  Google Scholar 

  28. Dong, P. T. et al. Polarization-sensitive stimulated Raman scattering imaging resolves amphotericin B orientation in Candida membrane. Sci. Adv https://doi.org/10.1126/sciadv.abd5230 (2021).

  29. Feng, X. et al. Proteomic discovery and array-based validation of biomarkers from urinary exosome by supramolecular probe. J. Proteome Res. https://doi.org/10.1021/acs.jproteome.3c00063 (2023).

  30. Koide, R. et al. Antiadhesive nanosome elicits role of glycocalyx of tumor cell-derived exosomes in the organotropic cancer metastasis. Biomaterials 280, 121314 (2022).

    Article  CAS  PubMed  Google Scholar 

  31. Chauhan, S. et al. Surface glycoproteins of exosomes shed by myeloid-derived suppressor cells contribute to function. J. Proteome Res. 16, 238–246 (2017).

    Article  CAS  PubMed  Google Scholar 

  32. Linares, R., Tan, S., Gounou, C., Arraud, N. & Brisson, A. R. High-speed centrifugation induces aggregation of extracellular vesicles. J. Extracell. Vesicles 4, 29509 (2015).

    Article  PubMed  Google Scholar 

  33. Martín-Gracia, B. et al. Nanoparticle-based biosensors for detection of extracellular vesicles in liquid biopsies. J. Mater. Chem. B 8, 6710–6738 (2020).

    Article  PubMed  Google Scholar 

  34. Castillo, J. et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann. Oncol. 29, 223–229 (2018).

    Article  CAS  PubMed  Google Scholar 

  35. Zhou, J. et al. Epitope imprinting of phospholipids by oriented assembly at the oil/water interface for the selective recognition of plasma membranes. Angew. Chem. Int. Ed. 62, e202213938 (2023).

    Article  CAS  Google Scholar 

  36. Gao, F. Y. et al. A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO2. Chem. Sci. 10, 1579–1588 (2019).

    Article  CAS  PubMed  Google Scholar 

  37. Pugholm, L. H., Revenfeld, A. L., Søndergaard, E. K. & Jørgensen, M. M. Antibody-based assays for phenotyping of extracellular vesicles. BioMed. Res. Int. 2015, 524817 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  38. MacBeath, G. & Schreiber, S. L. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760–1763 (2000).

    Article  CAS  PubMed  Google Scholar 

  39. Liu, Y. K. et al. One-pot analytical pipeline for efficient and sensitive proteomic analysis of extracellular vesicles. J. Proteome Res. 22, 3301–3310 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lee, Z. C., Hadisurya, M., Luo, Z., Li, L. & Tao, W. A. Hands-free proteomic profiling of urinary extracellular vesicles with a high-throughput automated workflow. J. Am. Soc. Mass. Spectrom. 34, 2585–2593 (2023).

    Article  CAS  PubMed  Google Scholar 

  41. Pan, L., Aguilar, H. A., Wang, L., Iliuk, A. & Tao, W. A. Three-dimensionally functionalized reverse phase glycoprotein array for cancer biomarker discovery and validation. J. Am. Chem. Soc. 138, 15311–15314 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Zhang, Y. et al. High-throughput phosphorylation screening and validation through Ti(IV)-nanopolymer functionalized reverse phase phosphoprotein array. Anal. Chem. 90, 10263–10270 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Chen, I. H. et al. Analytical pipeline for discovery and verification of glycoproteins from plasma-derived extracellular vesicles as breast cancer biomarkers. Anal. Chem. 90, 6307–6313 (2018).

    Article  CAS  PubMed  Google Scholar 

  44. Baghirova, A. A. & Kasumov, K. M. Antifungal macrocycle antibiotic amphotericin B—its present and future. Multidisciplinary perspective for the use in the medical practice. Biochem. Mosc. Suppl. B 16, 1–12 (2022).

    Article  CAS  Google Scholar 

  45. Cavassin, F. B., Bau-Carneiro, J. L., Vilas-Boas, R. R. & Queiroz-Telles, F. Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections. Infect. Dis. Ther. 10, 115–147 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lozano-Andrés, E. et al. Physical association of low density lipoprotein particles and extracellular vesicles unveiled by single particle analysis. J. Extracell. Vesicles 12, e12376 (2023).

    Article  PubMed  Google Scholar 

  47. Simonsen, J. B. What are we looking at? Extracellular vesicles, lipoproteins, or both? Circ. Res. 121, 920–922 (2017).

    Article  CAS  PubMed  Google Scholar 

  48. Yuana, Y. et al. Handling and storage of human body fluids for analysis of extracellular vesicles. J. Extracell. Vesicles https://doi.org/10.3402/jev.v4.29260 (2015).

  49. Iliuk, A. et al. Plasma-derived extracellular vesicle phosphoproteomics through chemical affinity purification. J. Proteome Res. 19, 2563–2574 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Shen, A. et al. High-throughput proteomic analysis of extracellular vesicles from saliva by chemical probe-based array. Anal. Chim. Acta 1309, 342699 (2024).

    Article  CAS  PubMed  Google Scholar 

  51. Daassi, D., Mahoney, K. M. & Freeman, G. J. The importance of exosomal PDL1 in tumour immune evasion. Nat. Rev. Immunol. 20, 209–215 (2020).

    Article  CAS  PubMed  Google Scholar 

  52. Costa, J. Glycoconjugates from extracellular vesicles: structures, functions and emerging potential as cancer biomarkers. Biochim. Biophys. Acta Rev. Cancer 1868, 157–166 (2017).

    Article  CAS  PubMed  Google Scholar 

  53. Ragni, E. et al. Protein O-mannosylation is crucial for human mesencyhmal stem cells fate. Cell. Mol. Life Sci. 73, 445–458 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Williams, C. et al. Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives. J. Extracell. Vesicles https://doi.org/10.1080/20013078.2018.1442985 (2018).

  55. Gao, L. et al. Legionella effector SetA as a general O-glucosyltransferase for eukaryotic proteins. Nat. Chem. Biol. 15, 213–216 (2019).

    Article  CAS  PubMed  Google Scholar 

  56. Lobb, R. J. et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles 4, 27031 (2015).

    Article  PubMed  Google Scholar 

  57. Shao, H. et al. New technologies for analysis of extracellular vesicles. Chem. Rev. 118, 1917–1950 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Vogel, R. et al. A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing. J. Extracell. Vesicles 5, 31242 (2016).

    Article  PubMed  Google Scholar 

  59. Yuana, Y. et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma. J. Extracell. Vesicles https://doi.org/10.3402/jev.v2i0.21494 (2013).

  60. Sharma, S. et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 4, 1921–1926 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Yang, Q. et al. Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer. J. Nanobiotechnol. 21, 153 (2023).

    Article  CAS  Google Scholar 

  62. Lokumcu, T. et al. Proteomic, metabolomic, and fatty acid profiling of small extracellular vesicles from glioblastoma stem-like cells and their role in tumor heterogeneity. ACS Nano 18, 2500–2519 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Andaluz Aguilar, H., Iliuk, A. B., Chen, I. H. & Tao, W. A. Sequential phosphoproteomics and N-glycoproteomics of plasma-derived extracellular vesicles. Nat. Protoc. 15, 161–180 (2020).

    Article  CAS  PubMed  Google Scholar 

  64. Ricklefs, F. L. et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci. Adv. https://doi.org/10.1126/sciadv.aar2766 (2018).

  65. Ye, L. et al. Prognostic significance and functional relevance of olfactomedin 4 in early-stage hepatocellular carcinoma. Clin. Transl. Gastroen. 11, e00124 (2020).

    Article  Google Scholar 

  66. Bausch-Fluck, D. et al. A mass spectrometric-derived cell surface protein atlas. PLoS ONE https://doi.org/10.1371/journal.pone.0121314 (2015).

  67. Bausch-Fluck, D. et al. The in silico human surfaceome. Proc. Natl Acad. Sci. USA 115, E10988–E10997 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Rai, A., Fang, H. Y., Claridge, B., Simpson, R. J. & Greening, D. W. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform. J. Extracell. Vesicles https://doi.org/10.1002/jev2.12164 (2021).

  69. Li, Y., Wang, J., Chen, W., Lu, H. & Zhang, Y. Comprehensive review of MS-based studies on N-glycoproteome and N-glycome of extracellular vesicles. Proteomics https://doi.org/10.1002/pmic.202300065 (2023).

  70. Lee, H. H. et al. Removal of N-linked glycosylation enhances PD-L1 detection and predicts anti-PD-1/PD-L1 therapeutic efficacy. Cancer Cell 36, 168–178.e164 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We sincerely thank X. Zhang at Jilin University/Tsinghua University for the help on concept proposing and experimental design of the project. This work was funded by National Science Foundation of China (22374056, 22174021), National Key R&D Program of China (2020YFE0202200, 2023YFA0915300) and Proteomic Navigator of The Human Body Project (π-HuB project).

Author information

Authors and Affiliations

Authors

Contributions

X.F., A.S. and L.H. designed the experimental protocol. X.F., A.S. and W.Z. performed all the experiments with help from S.J., A.I., Y.Z., Y.W. and W.Z. X.F. and A.S. wrote the manuscript with help from A.I., Y.Z., Y.W., W.Z. and W.A.T. X.F., A.S., W.A.T. and L.H. approved the final version. Y.Z., Y.W., W.Z., L.H. and W.A.T. provided advice and infrastructural support.

Corresponding authors

Correspondence to Ying Zhang, W. Andy Tao or Lianghai Hu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Protocols thanks Dennis Jeppesen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key references

Feng, X. et al. Anal. Chem. 95, 2812–2821 (2023): https://doi.org/10.1021/acs.analchem.2c04190

Feng, X. et al. J. Proteome Res. 22, 2516–2524 (2023): https://doi.org/10.1021/acs.jproteome.3c00063

Shen, A. et al. Anal. Chim. Acta. 1309, 342699 (2024): https://doi.org/10.1016/j.aca.2024.342699

Extended data

Extended Data Fig. 1 Flowchart for metabolic glycan labeling of cells and array-based EV capture/detection.

a. Metabolic glycan labeling of cells. b. Collection of cell culture medium and click chemistry reaction of EVs. c. ADSP array-based capture of EVs and fluorescent detection of labeled glycans. Figure created using BioRender.

Extended Data Fig. 2 The synthesized ADSP solution and the use of ADSP to modify the membranes.

a. ADSP solution after dialysis. The A340 is ~0.62. b. The ADSP-modified NC membrane finished product. Left: blank membrane, right: ADSP-modified membrane. c. ADSP solution measured at 340 nm after each modification to show the content. The overall use of ADSP solution is 0.24 mL per cm2 membrane. The effectiveness of the array after each modification is shown, demonstrating that ADSP below an A340 of 0.4 might be insufficient for modification.

Extended Data Fig. 3 Distribution and flow cytometry charts of EVs captured by ADSP array, generated using nanoflow cytometry.

“Plasma”, “Urine” and “Cell culture medium” refer to particles from different samples captured by and eluted from the ADSP-coated membrane, respectively. “Original” refers to particles from plasma samples captured and eluted by the ADSP-coated membrane. “Filtrate” represents the sEVs obtained from the original sample after passing through a 0.22 μm membrane filter. “Residue” denotes the particles from the original sample retained on the membrane filter, which are collected by washing with PBS. a. Histograms depicting the distribution of particles obtained from the plasma, urine, and cell culture medium. b. A size reference chart provided by Apogee for standard microspheres, enabling the determination of the size distribution of the test sample based on comparison with the standard microspheres. The term 4-9 with “black gate” refers to different populations of particles with varying particle sizes, whereas the term 1-3 with “red gate” signifies particle populations with different sizes and the presence of fluorescence signals. c. The Original, Filtrate, and Residue samples are stained with a membrane dye DiO and subsequently subjected to detection through the 488-channel by Apogee. Particles exhibiting fluorescence signals above the red line are identified as particles having membrane structures, while those below are considered as lacking membrane structures. Among the particles above the red line, those with membrane structures and falling within the size range to the left of the black line are identified as sEVs, while those to the right are categorized as lEVs.

Extended Data Fig. 4 Comparison of EVs enrichment efficiency between ADSP-membrane and UC with characterization by NTA.

Comparison of EV enrichment efficiency between ADSP-membrane and ultracentrifugation using NTA. ac show NTA characterization of plasma, urine and cell culture medium derived EVs captured by an ADSP membrane. The original volume of samples is: a. 10 µL of plasma diluted using PBS to a final volume of 2 mL; b. 2 mL of urine samples; c. 2 mL of cell culture medium samples. df show NTA characterization of plasma, urine and cell culture medium derived EVs enriched by ultracentrifugation. Original volumes of plasma, urine and cell culture medium were the same as ac. DPBS was used to adjust the ultracentrifugation precipitate to 1 mL for NTA assay.

Supplementary information

Supplementary Video 1

The use of the automated pipetting workstation for array-based capture of EVs.

Supplementary Video 2

The use of Smart Blotter for array-based capture of EVs.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, X., Shen, A., Zhang, W. et al. High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array. Nat Protoc 20, 1057–1081 (2025). https://doi.org/10.1038/s41596-024-01082-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41596-024-01082-z

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research